Position in ANVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,370
+$24,466 QoQ
Shares Held
30,307
+111.8% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 61 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ANVS ranks #295 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ANVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,370 | 30,307 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,904 | 14,307 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $49,501 | 14,307 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $20,174 | 9,746 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,148 | 9,746 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,618 | 9,746 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $49,022 | 9,746 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $78,552 | 9,746 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $50,382 | 8,747 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $104,731 | 8,801 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $164,559 | 8,800 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $83,426 | 8,791 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $125,609 | 8,790 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $135,360 | 8,784 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $117,955 | 8,783 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $120,312 | 8,782 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $99,576 | 8,781 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $117,172 | 8,777 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $154,299 | 8,777 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $310,419 | 9,777 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $45,955 | 537 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $697 | 25 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $173 | 23 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $110 | 23 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||